How Metabolic Health Is Reshaping Fertility Treatments in India

Fertility treatments in India are increasingly focusing on metabolic health as a key factor in success. Anupama, a 37-year-old advertising manager from Kochi, adjusted her approach midway through her assisted reproductive technology (ART) cycle after discovering borderline insulin levels. Her experience highlights a broader shift in how doctors now view insulin resistance as a critical variable in reproductive care.

Anupama had spent three years undergoing infertility treatment before starting her ART cycle. When her first embryo transfer failed, her doctor identified insulin resistance as a potential obstacle. This prompted her to reassess her treatment plan, incorporating stricter metabolic monitoring.

Over the past five years, Indian medical research—including studies by the Indian Society for Assisted Reproduction (ISAR) and AIIMS—has reinforced the link between metabolic health and fertility. Conditions like PCOS and metabolic syndrome now account for 30–40% of infertility cases among women, leading to updated protocols that combine lifestyle changes with medications like metformin.

Dr Suhasini Inamdar, a consultant at Motherhood Hospitals in Bengaluru, explains that insulin resistance affects ovulation, egg quality, and implantation. For women with PCOS, prediabetes, or obesity, managing glucose levels becomes as important as hormonal treatments. Anupama adjusted her diet, increased exercise, and worked to stabilise her insulin before her next cycle.

Dr Reji Mohan, an associate professor in reproductive medicine, also stresses the emotional toll of infertility, particularly for women dealing with obesity and stress. He advocates for sustainable habits rather than quick fixes, as metabolic improvements take time.

In her second attempt, Anupama's insulin levels were better controlled, and her treatment approach was more precise. This time, the procedure succeeded, resulting in a pregnancy.

Anupama's case reflects a growing trend in fertility care, where metabolic factors are now routinely addressed alongside traditional treatments. With insulin resistance recognised as a significant influence on reproductive outcomes, clinics are adopting more integrated strategies. For many women, this means longer preparation but potentially higher chances of success.